Siège social de Twist
681 Gateway Blvd
South San Francisco, CA 94080, États-Unis
On April 21st, 2020 Twist hosted Dr. Tilmann Buerckstuemmer, CSO of Aelian Biotechnology, who spoke about leveraging two transformative technologies - CRISPR screening and single cell transcriptomics - to enable genetic screening for complex phenotypes.
